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Abstract
To determine the role of NADPH-oxidase mediated formation of different lipid, 
protein-derived molecules, and depletion of vitamin-C level in vitreous behind 
the endothelial dysfunction-induced vascular endothelial growth factor secre-
tion and pathogenesis of diabetic retinopathy (DR) in type 2 diabetes mellitus 
(T2DM). Fourteen T2DM patients with mild non-proliferative diabetic retinopathy 
(MNPDR), 11 patients without diabetic retinopathy (DNR), 17 T2 DM subjects 
with high-risk proliferative diabetic retinopathy (HRPDR), and 5 healthy individu-
als without DM underwent vitreous analysis for estimation NADPH oxidase, lipid 
peroxide like malondialdehyde (MDA), 4-Hydroxy-noneal (HNE) and advanced 
lipoxidation end product (ALE) like Hexanoyl-lysine (HLY), protein carbonyl 
compound (PCC), Vitamin-C and concentration of vascular endothelial growth 
factor (VEGF) secretion following standard spectrophotometric methods and 
enzyme-linked immunosorbent assay (ELISA). Vitreous concentration of NADPH-
oxidase, different protein and lipid-derived molecule, and VEGF were found to 
be significantly elevated among DNR and of DR subjects with different grades 
compared to HC subjects whereasthe vitamin-C level was found to be decreased 
among different DR subjects and DNR subjects in comparison to healthy individu-
als. Oxidative stress-mediated lipid and protein-derived biomolecules not only add 
important mediators in the pathogenesis of DR, but also accelerate the progression 
and severity of microangiopathy.
Keywords: Diabetic retinopathy, NADPH-oxidase, Lipid peroxide, advanced 
lipoxidation end product, protein carbonyl compound
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1. Introduction
Despite remarkable advances in diagnosis and treatment, diabetic retinopathy 
(DR), the most frequently occurring complication causing vision loss in working 
population, is becoming the burning social problem. Two landmark studies have 
established that hyperglycemia is the principal contributing factor to the develop-
ment of the disease, though a reasonable portion of diabetic subjects develops 
this complication in spite of good control of blood sugar [1–3]. In a large densely 
populated country like India, where strict control of hyperglycemia is far from 
reality due to lack of clinic adherence, bad economy and illiteracy. Here, principal 
diet is carbohydrate since childhood. Enormous intracellular glucose in tissues 
including retina where glucose transport is insulin independent, overwhelms the 
glycolysis and citric acid cycle owing to gradual deficiency of oxidized cofactors 
i.e. nicotinamide adenine dinucleotide (NAD), flavin adenine dinucleotide (FAD), 
thiamine pyrophosphate (TPP), Coenzyme A and lipoate. The essential vitamins, 
the precursors of these factors could not be provided with only carbohydrates [4]. 
Unutilized glucose is diverted to anomalous biochemical pathways like sorbitol 
pathway, and advanced glycation end products formation [5]. Hexose monophos-
phate shunt (HMP-shunt) or pentose phosphate pathway (PPP) take-up glucose-
6-phosphate for its catabolism and produces specialized products like pentose 
ribose 5-phosphate to make RNA, DNA, and NADPH for reductive synthesis 
e.g. reduced glutathione peroxidase and fatty acids, the building blocks of lipid 
structure.
Beside reductive biosynthesis, NADPH carries life-saving roles to counter the 
damaging effects of oxygen radicals on erythrocytes, cells of lens, cornea and 
retina. Retina is a tissue where renewal of outer segment of photoreceptors is con-
tinuously going on in one side and other side shows light and oxygen induced death 
of cells as an inevitable phenomenon caused by oxidative stress.
Poorly controlled glycemia and lack of proper metabolism of glucose mainly 
result in formation and accumulation of advanced glycation end products (AGEs) 
and reactive oxygen species (ROS) which in turn cause microvascular endothelial 
cell dysfunction by oxidative modifications of membrane proteins and lipids [6]. 
Production of advanced lipoxidation end products (ALEs) during peroxidative 
damage of lipids may be the important source of protein modification by covalent 
bonding with catalytic site. Circulating AGEs and ALEs exert their detrimental 
effects through interactions with their cell surface receptor for AGE (RAGE) 
leading to post receptor activation of reduced nicotinamide adenine dinucleotide 
phosphate (NADPH) oxidase in endothelial cells, mesangial cells and macrophases 
[7]. Activation and subsequent uncoupling of NADPH oxidase is coupled with 
increased formation of intracellular reactive oxygen species. Activation of this 
system also follows the other pathways which suggest increased production of inter-
mediate of faster glycolysis e.g. glycerol 3-phosphate derived inositol triphosphate 
and diacylglycerol. Inositol triphosphate mediates a transient increase in the level 
of cytosolic Ca++which is essential for activation of NADPH oxidase and induction 
respiratoy burst e.g. generation of large amounts of superoxide anion, hydroxyl 
anion, and hydrogen peroxide [8].
Diacylglycerol (DAG) induces the translocation of protein kinase C (PKC) into 
plasma membrane from cytosol, where it catalyzes the phosphorylation of vari-
ous proteins including the components of NADPH oxidase, and thus activates this 
system [9].
Beside structural modifications of retinal membrane, AGEs and ALEs invite 
up regulation of inflammatory mediators and adhesion molecules in capillary 
beds which cause apoptosis of endothelial cell and breakdown of tight junctions 
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of blood-retinal barrier [10]. Active vitamin C is ascorbic acid and acts as a donor 
of reducing equivalents which is capable of reducing compounds as molecular 
oxygen, nitrate and cytochromes a and c. This ascorbic acid acts as a water soluble 
antioxidant reduce oxidized tocopherol in lipid membranes [11]. Such vitamin is 
also required for hydroxylation of amino acids, proline and lysine in the synthesis 
of collagen [12]. So, deficiency of vitamin C leading to defective collagen synthesis 
and accumulation of reactive carbonyl compounds due to oxidative stress results in 
fragility of retinal capillary membranes and enhancement of break-down of inner 
blood-retinal barrier. In this study we attempted to determine the accompanying 
role of different lipid derived toxic molecules and deficiency of antioxidant in the 
pathogenesis of an inflammatory disease, DR.
2. Methodology
A number of 17 subjects with high-risk proliferative diabetic retinopathy 
(HRPDR), 14 subjects with mild non-proliferative DR (MNPDR), 11 age and 
gender-matched diabetic subjects without clinically evident retinopathy (DNR), 
and 5 healthy controls (HCs), whose clinical condition independently indicated for 
vitrectomy were enrolled in the present cross-sectional study. Subjects with hyper-
tension (systolic BP > 140 mm Hg and or diastolic BP > 90 mm Hg), cardiovascular 
diseases, neuropathy (assessed by Michigan Neuropathy Screening Instrument), 
nephropathy (serum creatinine level > 1.5 mg/dl and or urinary albumin creatinine 
ratio 300 μg/mg), deficiency of B vitamins, any other ocular diseases (glaucoma, 
optic neuropathy, cataract, branch retinal vein occlusion, and Eales disease) were 
excluded from the study. The subjects were chosen consecutively from the ‘Outdoor 
Patient Department’ of ‘Regional Institute of Ophthalmology, Calcutta Medical 
College, West Bengal, and Kolkata, India. The institutional ethical committee was 
approved the study and informed consent was collected from all the study subjects 
according to the Helsinki guideline.
Subjects with type 2 DM were diagnosed according to the guideline of the 
American Diabetes Association (2010). The fasting plasma glucose (FPG), 
postprandial plasma glucose (PPG), and glycated hemoglobin (HbA1c %) levels 
were used for the assessment of the glycaemic status of each subject. None 
of the study subjects were taking insulin or lipid-lowering drugs during the 
study period.
2.1 Comprehensive ophthalmological examinations
The subjects enrolled in the study had undergone different ophthalmologi-
cal examinations which included slit-lamp biomicroscopy (by ±90 diopters and 
Goldman 3 mirror lens), seven fields of digital fundus photography with fluorescein 
angiography, and spectral-domain optical coherence tomography (SD-OCT). Visual 
functions were evaluated by measuring VA. The subjects with different grades of 
DR were diagnosed according to the modified guideline of ‘Early Treatment of 
Diabetic Retinopathy Study’ [13].
2.2 Collection of vitreous sample
Vitreous samples from study subjects were drawn by 3-port parsplana vit-
rectomy during surgery of vitreous hemorrhage, of idiopathic macular hole or 
removal of a dropped nucleus which occurred accidentally after blunt trauma. 
Vitreous was also collected during management of preoperative complication of 
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phacoemulsification. Undiluted vitreous gel (500 μL) was excised from midvitreous 
by vitreous cutter and carefully aspirated into the hand-held sterile syringe attached 
to the suction port of the vitrectomy probe. Immediately after collection, the vitre-
ous samples were taken in micro centrifuged tube and centrifuged at 3000 rpm for 
5 minutes. The clear solution without any precipitate was then collected in another 
tube and preserved in - 80° C for farther use.
2.3 Measurement of NADPH oxidase activity
NADPH oxidase activity was measured in vitreous using Nitrobluetetrazolium 
(NBT) as the substrate. Briefly, 100 μl plasma/ vitreous was mixed with NBT 
(4 mg/ml in water) and incubated for 20 minutes at 37°C. 1 M HCl was used 
to terminate the reaction. Then the samples were centrifuged at 3500 rpm for 
5 minutes. 400 μl Dimethylsulfoxide (DMSO) was added to form a stable triphenyl-
methyl ester whose absorbance was measured at 550 nm using a microplate reader 
(MerilyzerEiaquant, Meril Diagnostics Pvt. Ltd., Vapi, Gujarat). OD 550 is directly 
proportional to NADPH oxidase activity [14].
2.4 Measurement of vitamin C level
Vitamin C level was measured by the protocol of Kyaw et al. [15]. Briefly, 
the colored reagent was prepared using Sodium Tungstate, DisodiumHydrogen 
Phosphate, H2SO4 and distilled water. Plasma/vitreous sample (1 ml) was thor-
oughlymixed with 2 ml colored reagent. After 30 minutes incubation at room 
temperature (RT) the tubes were centrifuged at 3000 pm for 10 minutes. The 
absorbance was measured at 700 nm from the supernatant, without disturbing the 
precipitate. Standard curve was prepared using oxalic acid and distilled water is 
used as substrate blank in the experiment. The vitamin C concentration in samples 
was expressed in mg/dl.
2.5 Measurement of protein carbonylation (PCC)
Protein carbonylation was measured from vitreous by spectrophotometric 
method by protein derivatization with 2, 4-dinitrophenyl-hydrazine (DNPH). 
Briefly, protein lysates from vitreous (50 μl) were incubated in dark for 30 min-
utes with DNPH (10 mM in 2 N HCl, 100 μl). After that TCA (20%, 100 μl) 
was used to precipitate proteins and free DNPH was removed by washing with 
ethanol-ethyl acetate (1:1). The resultant pellet was dissolved in 350 μl of sodium 
dodecyl sulfate (2% SDS) and protein-hydrazone complex’s absorbance was 
measured at 370 nm using spectrophotometer. The carbonyl concentration was 
calculated using the extinction coefficient of the protein-hydrazone complex 
(22,000 M−1 cm−1) from the specific absorption (relative to the reagent blank). 
The final concentration was expressed as nanomoles of carbonyl groups per mil-
ligram protein [16–18].
2.6 Estimation of malondialdehyde (MDA)
The MDA level in vitreous was measured by thiobarbituric acid (TBA) assay 
method. In the assay procedure, the plasma samples were first reacted with trichlo-
roacetic acid (TCA) to remove proteins. Then chromogenic adducts of MDA was 
precipitated using TBA. Finally the precipitated MDA was extracted using n-butyl 
alcohol, by vigorous shaking. Then the chromogenic adduct was measured spectro-
photometrically at 532 nm; the results were expressed as mM/L [19].
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2.7 Measurement of HNE
Human vitreous HNE was estimated by competitive inhibition enzyme immunoas-
say technique (ELISA) using research kit from CUSABIO (cat no: CSB-E16214h). In 
the assay, an antibody specific for human HNE was coated on the well plate. A series of 
standards ranging from 39 pg/ml to 2500 pg/ml and samples (vitreous samples were 
run in 5 fold diluted form respectively) were added into the wells with Horseradish 
Peroxide (HRP) conjugated HNE. The competitive inhibition reaction was launched 
between HRP conjugated HNE and HNE in the samples. Then a substrate solution 
was added to the wells and the color developed is inversely proportional to the amount 
of HNE in the sample. The color development was stopped using stop solution and 
the intensity of the color was measured colorimetrically by using 450 nm filter in an 
ELISA plate reader MerilyzerEiaquant (Meril Diagnostics Pvt. Ltd., Vapi, Gujarat).
2.8 Measurement of HLY
Human vitreous HLY was estimated also by competitive enzyme immunoas-
say technique using commercial kits (MyBiosource, Catalog no: MBS753480) and 
utilizing a polyclonal anti-HLY antibody and an HLY-HRP conjugate. At first the 
assay sample and buffer were incubated together with HLY-HRP conjugate in pre-
coated plate for one hour. After the incubation period, the wells were decanted and 
washed five times. The wells were then incubated with a substrate for HRP enzyme. 
The product of the enzyme-substrate reaction forms a blue colored complex. Then, 
a stop solution was added to stop the reaction, which will then turn the solution 
yellow. The intensity of color was measured spectrophotometrically at 450 nm in a 
microplate reader. The intensity of the color was inversely proportional to the HLY 
concentration present in the sample. A standard curve was also plotted relating the 
intensity of the color (or O.D.) to the concentration of standards. The HLY concen-
tration in each sample was interpolated from this standard curve.
2.9 Measurement of VEGF
Human vitreous VEGF was estimated by sandwich enzyme-linked immune 
sorbent assay (ELISA) method using Ray Biotech kit (cat no: ELH-VEGF-001, 
Norcross USA). In the assay, an antibody specific for human VEGF was coated 
on the well plate. A series of standards ranging from 8.23 pg/ml to 6000 pg/ml 
and samples (vitreous samples were run in a half diluted form respectively) were 
added into the wells. VEGF protein present in the sample was bound to the wells by 
the immobilized antibody. The wells were washed and a biotinylated anti-human 
VEGF antibody was added. After buffer washing, HRP –conjugated streptavidin 
was pipette to wash and TMB substrate solution was added into the wells and was 
placed in incubation at room temperature for 30 minutes. The intensity of the final 
color product was proportional to the concentration of VEGF protein present in 
the samples and absorbance of the color product was measured colorimetrically by 
using 450 nm filter in an ELISA plate reader MerilyzerEiaquant (Meril Diagnostics 
Pvt. Ltd., Vapi, Gujarat). The concentration of VEGF was determined by a stan-
dard curve and the assay detects less than 10 pg/ml of VEGF from the sample.
3. Results
As shown in the Table 1, different study groups enrolled in the present study 
showed no statistically significant differences for age, gender distributions, body 
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mass index (BMI), and duration of diabetes, systolic and diastolic blood pressure. 
Glycaemic parameters like FPG level were found to be increased significantly in the 
DNR (p < 0.05), MNPDR (p < 0.01), and HRPDR (p < 0.01) subjects compared 
to the HCs. Similarly, the PPG level were found to be increased significantly in the 
DNR (p < 0.05), MNPDR (p < 0.01), and HRPDR (p < 0.0001) subjects compared 
to the HCs. Regarding, HbA1C DNR (p < 0.05), MNPDR (p < 0.001), and HRPDR 
(p < 0.05) subjects showed significantly higher values of HbA1c compared to HCs. 
However, statistical analysis showed no significant differences in FPG, PPG, and 
HbA1C levels between DNR, MNPDR, and HRPDR subjects.
Vitreous NADPH oxidase activity was found to be increased significantly among 
DNR (0.217 ± 0.031 OD550/100 μL, vitreous, p < 0.0001), MNPDR (0.286 ± 0.033 
OD550/100 μL, vitreous, p < 0.0001), and HRPDR (0.365 ± 0.032 OD550/100 μL, vit-
reous, p < 0.0001) subjects compared to HC (0.121 ± 0.018 OD550/100 μL, vitreous) 
subjects. Again, both the MNPDR (p < 0.01) and HRPDR subjects (p < 0.0001) 
showed significantly higher level of NADPH oxidase than DNRs. Further, the 
HRPDR subjects showed a higher NADPH oxidase level (p < 0.0001) than the 
former (Figure 1A).
Regarding vitamin-C concentration in vitreous, the DNR (0.807 ± 0.043 mg/dl,  
p < 0.01), MNPDR (0.874 ± 0.061 mg/dl, p < 0.0001), and HRPDR 
(0.970 ± 0.110 mg/dl, p < 0.0001) subjects showed lower vitamin-C level com-
pared to HC (0.682 ± 0.038 mg/dl) subjects. Again, both the MNPDR (p < 0.05) 
and HRPDR subjects (p < 0.0001) showed significantly lower level of vitamin-C 
than DNRs. HRPDR subjects showed a lower vitamin-C level (p < 0.01) than the 
MNPDR ones (Figure 1B).









Age (years) 52.00 ± 7.48 51.29 ± 5.46 52.64 ± 2.853 50.94 ± 7.45 0.905
Gender M 3(60%) 6(54.54%) 7(50%) 8(47.05%) 0.954
F 2(40%) 5(45.45%) 7(50%) 9(52.94%)
BMI (kg/m2) 23.30 ± 3.54 25.15 ± 2.183 26.61 ± 4.349 23.15 ± 6.54 0.439
Duration of 
DM (years)





80.46 ± 8.48 153.5 ± 9.55* 159.3 ± 28.50†† 154.9 ± 16.11!!!! 0.0001
PPG 
(mg/dl)
118.2 ± 11.19 182.0 ± 33.00* 193.5 ± 62.14†† 218.4 ± 32.16!! 0.005
HbA1C 
(%)
4.81 ± 0.290 7.61 ± 0.476* 8.43 ± 1.117††† 7.78 ± 1.102! 0.002
HC, healthy control; DNR, diabetic subjects without clinically evident retinopathy, MNPDR, early non-proliferative 
diabetic retinopathy; HRPDR, high-risk proliferative diabetic retinopathy; BMI, body mass index; FPG, 
fasting plasma glucose, PPG, postprandial plasma glucose; HbA1C, glycated haemoglobin. The Kruskal Wallis 
nonparametric ANOVA followed by Dunn's multiple comparisons test was administrated to find out significant 
differences between the groups. A value of p < 0.05 was considered as statistically significant.
*HC vs DNR, p < 0.05.
†††HC vs MNPDR, p < 001.
††HC vs MNPDR, p < 0.01.
!!!!HC vs HRPDR, p < 0001.
!!HC vs HRPDR, p < 0.01.
!, HC vs HRPDR, p < 0.05.
Table 1. 
Demographic and clinical characteristics of study subjects.
7
Role of Lipid, Protein-Derived Toxic Molecules, and Deficiency of Antioxidants…
DOI: http://dx.doi.org/10.5772/intechopen.99904
Vitreous PCC concentration was found to be increased significantly among DNR 
(41.57 ± 19.96 nmol/mg protein, p < 0.05), MNPDR (65.43 ± 17.31 nmol/mg protein, 
p < 0.001), and HRPDR (88.65 ± 24.93 nmol/mg protein, p < 0.0001) subjects 
compared to HC (18.46 ± 7.18 nmol/mg protein) subjects. Again, both the MNPDR 
(p < 0.05) and HRPDR subjects (p < 0.0001) showed significantly higher level of 
PCC than DNRs. Further, the HRPDR subjects showed a higher PCC level (p < 0.01) 
than the former (Figure 1C).
Vitreous MDA level was found to be increased significantly among DNR 
(2.814 ± 0.482 μM/L, p < 0.01), MNPDR (4.58 ± 0.655 μM/L, p < 0.0001), 
and HRPDR (8.51 ± 1.23 μM/L, p < 0.0001) subjects compared to HC 
(1.129 ± 0.579 μM/L) subjects. Again, both the MNPDR (p < 0.0001) and HRPDR 
subjects (p < 0.0001) showed significantly higher level of MDA than DNRs. 
Further, the HRPDR subjects showed a higher MDA level (p < 0.0001) than 
MNPDR subjects (Figure 2A).
Regarding HNE concentration in vitreous, the DNR (3936 ± 457.2 pg/ml,  
p < 0.0001), MNPDR (8643 ± 771.8 pg/ml, p < 0.0001), and HRPDR 
(7407 ± 622.3 pg/ml, p < 0.0001) subjects showed higher HNE level compared 
to HC (2092 ± 1201 pg/ml) subjects. Again, both the MNPDR (p < 0.0001) and 
HRPDR subjects (p < 0.0001) showed significantly higher level of HNE than DNRs. 
HRPDR subjects showed a higher HNE level (p < 0.0001) than the MNPDR ones 
(Figure 2B).
Vitreous HLY level was found to be increased significantly among DNR 
(70.93 ± 16.29 nmol/L, p < 0.0001), MNPDR (113.0 ± 10.56 nmol/L, p < 0.0001), 
and HRPDR (132.1 ± 16.22 nmol/L, p < 0.0001) subjects compared to HC 
(30.68 ± 7.29 nmol/L) subjects. Again, both the MNPDR (p < 0.01) and HRPDR 
subjects (p < 0.0001) showed significantly higher level of HLY than DNRs. Further, 
the HRPDR subjects showed a higher HLY level (p < 0.01) than MNPDR subjects 
(Figure 2C).
Vitreous VEGF level was found to be increased significantly among DNR 
(90.53 ± 5.611 pg/ml, p < 0.05), MNPDR (117.0 ± 17.09 pg/ml, p < 0.0001), 
and HRPDR (131.3 ± 12.21 pg/ml, p < 0.0001) subjects compared to HC 
(72.06 ± 5.109 pg/ml) subjects. Again, both the MNPDR (p < 0.0001) and HRPDR 
subjects (p < 0.0001) showed significantly higher level of VEGF than DNRs. 
Further, the HRPDR subjects showed a higher VEGF level (p < 0.05) than MNPDR 
subjects (Figure 2D).
In the DNR and DR group, vitreous NADPH activity showed significant posi-
tive correlations with PCC, MDA, HNE, and HLY respectively. However, the study 
showed no significant correlation with the same in the HC group (Table 2).
Figure 1. 
Comparison of vitreous level NADPH oxidase, vitamin-C and protein carbonyl compound among study groups. 
[A] Comparison of vitreous level NADPH oxidase, [B] Comparison of vitreous level vitamin-C, [C] Comparison 
of vitreous level protein carbonyl compound. The one way ANOVA followed by Tuky’s comparisons test was 
administrated to find out significant differences between the groups. A value of p < 0.05 was considered as 
statistically significant.
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The VEGF level of vitreous showed a significant negative correlation with 
vitamin-C and positive correlations with PCC, MDA, HNE, and HLY levels respec-
tively in both DNR and DR groups. However, the study showed no significant 
correlation with the same in the HC group (Table 3).
Parameters HC group DNR group DR group
Vitamin-C r = 0.16, p = 0.722 r = -0.755, p = .007 r = -.451, p = 0.035
PCC r = 0.235, p = 0.684 r = 0.774, p = 0.009 r = .748, p < 0.0001
MDA r = 0.285, p = 0.691 r = 0.810, p = 0.003 r = .660, p = 0.003
HNE r = 0.085, p = 0.875 r = 0.871, p < 0.0001 r = .807, p < 0.0001
HLY r = 0.145, p = 0.802 r = 0.783, p = 0.007 r = .655, p = 0.002
A Pearson or Spearman correlation coefficient (r) was used and p < 0.05 was considered statistically significant.
Table 3. 
Correlation of vitamin-C, PCC, MDA, HNE and ALE with VEGF in different study groups.
Figure 2. 
Comparison of vitreous level MDA, HNE, HLY and VEGF among study groups. [A] Comparison of vitreous 
level MDA, [B] Comparison of vitreous level HNE, [C] Comparison of vitreous level HLY, [D] Comparison 
of vitreous level VEGF. The one way ANOVA followed by Tuky’s comparisons test was administrated to find out 
significant differences between the groups. A value of p < 0.05 was considered as statistically significant.
Study 
groups
PCC MDA HNE HLY
HC r = 0.300, p = 0.491 r = 0.205, p = 0.741 r = 0.200, p = 0.825 r = 0.100, p = 0.100
DNR r = 0.833, p = 0.005 r = 0.673, p = 0.033 r = 0.632, p = 0.040 r = 0.733, p = 0.040
DR r = 0.667, p < 0.0001 r = 0.768, p < 0.0001 r = 0.891, p < 0.0001 r = 0.726, p < 0.0001
A Pearson or spearman correlation coefficient (r) was used and p < 0.05 was considered statistically significant.
Table 2. 
Correlation of vitreous NADPH oxidase activity with PCC, MDA, HNE and HLY in HC, DNR and DR 
(MNPDR+HRPDR) group.
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4. Discussion
Our study showed that a gradual increment of NADPH Oxidase activity with 
the pathogenesis and severity of DR (HC < DNR < MNPDR< HRPDR). However 
there is no direct evidence regarding gradual increment and association of NADPH 
Oxiadse activity with different graded of DR. An in-Vitro study, Meng et al. [20] 
demonstrated that NADPH Oxidase augment insulin-induced VEGF expression and 
angiogenesis. In another study by Ushio-Fukai, [21] also showed that VEGF expres-
sion is augmented through ROS, produced by NADPH Oxidase.
Vitreous level of vitamin C was also found to be declined with pathogenesis and 
severity of DR (HC >  DNR > MNPDR >  HRPDR). However there is lack of 
evidence between vitreous level of Vitamin C and different stages of DR. Vitamin C 
suppress the VEGF gene expression through HIF-1α pathway [22].
Vitreous PCC level was found to be increase gradually with progression of 
DR (HC < DNR < MNPDR< HRPDR). Nevertheless there is no such evidence of 
vitreous level of PCC and different stages of DR. Loukovaara et al. [23] shown that 
amount of protein carbonylation and HIF-1α elevated in vitreous of PDR subjects.
The present study showed a gradual increment of LPO products like MDA and 
HNE and ALE like HLY both in plasma and vitreous sample towards the develop-
ment and progression of DR. The studies by Chatziralli et al. [24], Mondal et al., 
[4] also showed plasma MDA level increases towards the DR pathogenesis and 
progression. Another study by Mancino et al. [25] showed that vitreous MDA level 
increases among NPDR and PDR subjects compared to nondiabetic HC subjects. 
Researchers have demonstrated that the MDA compound is associated with protein 
modification in a pH-dependent fashion. At the physiological pH, it rapidly forms 
enolates, which are of lower reactivity and do not react as avidly with nucleo-
philic species as other aldehydes [26]. However, at a lower pH, MDA exists as 
b-hydroxyacrolein form, exhibiting a higher reactivity, readily reacting with Lys 
residues of proteins to form the enaminal type MDA adduct, N ϵ -(2-propenal)
lysine, and the fluorescent product, dihydropyridine (DHP) lysine and thereby 
alters proteins structure and functions [27]. On the other hand, the role of HNE 
in diabetes and its complications is not well understood [28]. Clinical studies have 
reported elevated levels of HNE in the blood of diabetic patients with retinopathy 
compared to those without retinopathy and healthy controls [29]. There is also 
evidence showing that HNE and HNE-derived ALEs increase in the retinas of rats 
rendered diabetic for 4-6 weeks [30]. Another study confirmed these findings 
and showed that HNE may contribute to the pathogenesis of DR by activating the 
WNT signaling pathway through stabilization of the WNT co-receptor LRP6 [31]. 
Other animal studies have linked HNE to retinal hemodynamics changes during 
DR. Retinal perfusion deficits during early diabetes are thought to be mediated, at 
least in part, through the reduced activity of large-conductance Ca2 + −activated 
K+ (BK) channels on the retinal vascular smooth muscle cells, causing vasocon-
striction [32, 33]. HNE impairs BK channel function in rat retinal arterioles, as 
demonstrated by reduced vasodilatory responses to the BK channel opener, BMS-
191011 [34]. HNE exposure is reported to result in endoplasmic reticulum stress, 
mitochondrial dysfunction, and apoptosis in cultures of human retinal capillary 
pericytes and Müller glia [35].
The ALE component like HLY also found to be increased with the pathogenesis 
and severity of DR in the present study. A previous study by [36] reported a signifi-
cant elevation of ALE levels among DNR and MNPDR subjects compared to HCs. 
Moreover, significant elevation of HLY in the vitreous and serum of patients with 
PDR was also observed by Izuta et al. [37], which is following our findings.
Diabetic Eye Disease - From Therapeutic Pipeline to the Real World
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The study showed a significant negative correlation of VEGF with Vitamin-C 
level and positive correlations with PCC, MDA, HNE, and HLY. Decrease vitamin 
C level with increased NADPH oxidase activity may turn oxidative stress, which 
further damages protein and lipids subsequently causes endothelial dysfunction 
induced VEGF secretion.
5. Conclusion
Oxidative stress-mediated lipid and protein-derived biomolecules not only add 
important mediators in the pathogenesis of DR, but also accelerate the progression 
and severity of microangiopathy.
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